Shareholding disclosure

ADDEX PHARMACEUTICALS LTD

Declared position

13.88%

Threshold

Crossed downwards

Timeline

Published

19.03.2011

Transaction

14.03.2011

Voting rights breakdown

Voting rights acquired2.02%

Voting rights sold13.88%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAB3F00020

Beneficial owner

ADDEX PHARMACEUTICALS LTD

Declared address

ADDEX PHARMACEUTICALS LTD, 1228 PLAN-LES-OUATES

Conversion de bons sans coupons à conversion obligatoire en actions ordinaires déclenchant le franchissement des seuils de 33.33%, 25%, 20% et 15% à la baisse en positions d'aliénation.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX PHARMACEUTICALS LTD

Addex Therapeutics Ltd19.03.2011TAB3F00020

Disclosure summary

ADDEX PHARMACEUTICALS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 19.03.2011, at 13.88% of voting rights. Notice category: Single shareholder.

Disclosed position

13.88%

Voting rights sold

Voting rights acquired2.02%

Voting rights sold13.88%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX PHARMACEUTICALS LTD disclosed a holding in Addex Therapeutics Ltd, published on 19.03.2011.

Publication date19.03.2011

Transaction date14.03.2011

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX PHARMACEUTICALS LTD

Declared addressADDEX PHARMACEUTICALS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired2.02%

Voting rights sold13.88%

Below threshold0%

ExchangeXSWX

Notification IDTAB3F00020

Conditions

Conversion de bons sans coupons à conversion obligatoire en actions ordinaires déclenchant le franchissement des seuils de 33.33%, 25%, 20% et 15% à la baisse en positions d'aliénation.

Source: SIX Exchange Regulation · Publication date: 19.03.2011

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open